Nathan Robison

2.5k total citations
49 papers, 969 citations indexed

About

Nathan Robison is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Nathan Robison has authored 49 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 23 papers in Neurology and 17 papers in Molecular Biology. Recurrent topics in Nathan Robison's work include Glioma Diagnosis and Treatment (33 papers), Neuroblastoma Research and Treatments (18 papers) and Brain Metastases and Treatment (8 papers). Nathan Robison is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Neuroblastoma Research and Treatments (18 papers) and Brain Metastases and Treatment (8 papers). Nathan Robison collaborates with scholars based in United States, Germany and Bolivia. Nathan Robison's co-authors include Mark W. Kieran, Ashley Margol, Girish Dhall, Peter Manley, Susan Chi, Nicole J. Ullrich, Wendy B. London, Liliana Goumnerova, Shahab Asgharzadeh and Karen J. Marcus and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Nathan Robison

43 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Robison United States 16 572 349 270 129 127 49 969
Anu Banerjee United States 16 597 1.0× 355 1.0× 282 1.0× 152 1.2× 150 1.2× 32 956
Marc H.A. Jansen Netherlands 18 497 0.9× 261 0.7× 224 0.8× 178 1.4× 118 0.9× 42 921
Amedeo A. Azizi Austria 17 435 0.8× 335 1.0× 284 1.1× 224 1.7× 180 1.4× 76 907
Eric Lipp United States 19 488 0.9× 139 0.4× 246 0.9× 186 1.4× 133 1.0× 85 940
Adam L. Green United States 19 283 0.5× 153 0.4× 376 1.4× 121 0.9× 187 1.5× 55 923
Lucas Moreno Spain 22 340 0.6× 642 1.8× 521 1.9× 140 1.1× 203 1.6× 93 1.4k
Bożenna Dembowska–Bagińska Poland 17 239 0.4× 143 0.4× 448 1.7× 154 1.2× 111 0.9× 68 1.0k
Armin Muigg Austria 11 315 0.6× 123 0.4× 220 0.8× 171 1.3× 48 0.4× 23 883
Martin Mynarek Germany 16 307 0.5× 131 0.4× 197 0.7× 114 0.9× 168 1.3× 47 672
Stephen P. Lowis United Kingdom 19 288 0.5× 182 0.5× 289 1.1× 156 1.2× 77 0.6× 44 773

Countries citing papers authored by Nathan Robison

Since Specialization
Citations

This map shows the geographic impact of Nathan Robison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Robison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Robison more than expected).

Fields of papers citing papers by Nathan Robison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Robison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Robison. The network helps show where Nathan Robison may publish in the future.

Co-authorship network of co-authors of Nathan Robison

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Robison. A scholar is included among the top collaborators of Nathan Robison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Robison. Nathan Robison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fangusaro, Jason, Arzu Onar‐Thomas, Tina Young Poussaint, et al.. (2025). A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 27(9). 2415–2428. 2 indexed citations
2.
3.
4.
Margol, Ashley, et al.. (2023). OUTC-06. BEST PRACTICES FOR THE SUCCESSFUL ADMINISTRATION OF COMBINATION METRONOMIC ANTI-ANGIOGENIC AND INTRAVENTRICULAR THERAPY. Neuro-Oncology. 25(Supplement_1). i36–i36. 1 indexed citations
5.
Buckley, Jonathan D., Ryan J. Schmidt, Dejerianne Ostrow, et al.. (2023). An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors. Journal of Molecular Diagnostics. 26(2). 127–139. 3 indexed citations
6.
Monje, Michelle, Tabitha Cooney, John Glod, et al.. (2023). Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-Oncology. 25(12). 2262–2272. 31 indexed citations
7.
8.
Robison, Nathan, et al.. (2022). Cardiac Function in Children and Young Adults Treated with MEK Inhibitors: A Retrospective Cohort Study. Pediatric Cardiology. 43(6). 1223–1228. 1 indexed citations
9.
Ullrich, Nicole J., Sanjay P. Prabhu, Roger J. Packer, et al.. (2020). Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children. Pediatric Blood & Cancer. 68(4). e28833–e28833. 13 indexed citations
10.
Yeo, Kee Kiat, Ashley Margol, Rebekah Kennedy, et al.. (2019). Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens. Journal of Neuro-Oncology. 145(2). 375–383. 9 indexed citations
11.
Robison, Nathan, Kee Kiat Yeo, Jemily Malvar, et al.. (2018). Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. Journal of Neuro-Oncology. 138(1). 199–207. 11 indexed citations
12.
Trost, Margaret, et al.. (2018). Changing Trends in Brain Imaging Technique for Pediatric Patients with Ventriculoperitoneal Shunts. Pediatric Neurosurgery. 53(2). 116–120. 12 indexed citations
13.
Margol, Ashley, Kee Kiat Yeo, Caihong Xia, et al.. (2018). A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group. Journal of Neuro-Oncology. 140(3). 575–582. 9 indexed citations
14.
Margol, Ashley, Nathan Robison, Long Hung, et al.. (2014). Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas. Clinical Cancer Research. 21(6). 1457–1465. 86 indexed citations
15.
Robison, Nathan & Mark W. Kieran. (2014). Diffuse intrinsic pontine glioma: a reassessment. Journal of Neuro-Oncology. 119(1). 7–15. 79 indexed citations
16.
Erdreich‐Epstein, Anat, Nathan Robison, Xiuhai Ren, et al.. (2013). PID1 ( NYGGF4 ), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas. Clinical Cancer Research. 20(4). 827–836. 26 indexed citations
17.
Liu, Daofeng, Liping Song, Vita S. Brawley, et al.. (2013). Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clinical Immunology. 149(1). 55–64. 61 indexed citations
18.
Stapleton, Christopher J., Brian P. Walcott, Kristopher T. Kahle, et al.. (2011). Diffuse central neurocytoma with craniospinal dissemination. Journal of Clinical Neuroscience. 19(1). 163–166. 9 indexed citations
19.
Robison, Nathan, et al.. (2009). Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden. Pediatric Blood & Cancer. 52(7). 867–869. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anu Banerjee Breakdown of academic impact, for papers by Marc H.A. Jansen Breakdown of academic impact, for papers by Amedeo A. Azizi Breakdown of academic impact, for papers by Eric Lipp Breakdown of academic impact, for papers by Adam L. Green Breakdown of academic impact, for papers by Lucas Moreno Breakdown of academic impact, for papers by Bożenna Dembowska–Bagińska Breakdown of academic impact, for papers by Armin Muigg Breakdown of academic impact, for papers by Martin Mynarek Breakdown of academic impact, for papers by Stephen P. Lowis
Rankless by CCL
2026